Tag Archives: Off-Label Marketing

Novartis Pays $35 Million to Settle False Claims Case

Novartis Pharmaceuticals Corporation has paid more than $35 million to resolve federal and state False Claims Act allegations resulting from the off-label marketing for Elidel. Elidel is a cream approved by the Food and Drug Administration to treat eczema in … Continue reading

Posted in Compliance, Fraud & Abuse, NEWS, Pharmaceutical | Tagged | Comments Off on Novartis Pays $35 Million to Settle False Claims Case

Abbott Labs Could Face $1B Whistleblower Fine for Off-Label Use of Stents

Abbott Laboratories could face a $1 billion fine in a federal whistle-blower lawsuit over off-label use of stents, and allegations of Medicare fraud and kickbacks paid to hospitals and physicians for such use. The jury trial began this week in … Continue reading

Posted in Compliance, Fraud & Abuse, NEWS, Whistleblower | Tagged , | Comments Off on Abbott Labs Could Face $1B Whistleblower Fine for Off-Label Use of Stents